🔥Telegram İfşa

We have signed a global research #collaboration agreement with MSD to discover and validate modulators of up to five therapeutic targets. #drugdiscovery #biotech curvetx.com/curve-therapeu…

Happy to see CurveTX announce a multi-target collaboration with MSD this morning. A big thank you to all CurveTX team who have worked tirelessly throughout the pandemic, and to University of Southampton & @UoSChemistry for their support. More information via the link👇

Merck Inks Up-to-$1.7B Small Molecule Partnership Merck will apply CurveTX mammalian cell #drugdiscovery platform to identify and optimize novel small molecule drug candidates against targets to be selected by the pharma giant...Read more: ow.ly/7Wz950HXcbX

Curve Inks Mammoth Deal With MSD Just Three Years After $6.1m Seed Funding bit.ly/3LH23Fh #PharmaScrip

Excited to announce that University of Southampton spinout CurveTX founded by Ali Tavassoli signed a $1.7 billion deal with multinational pharmaceutical company MSD. They will collaborate on research using CurveTX drug discovery platform. Read more: fal.cn/3moQl?

.Merck is collaborating with UK #biotech CurveTX. The partners aim to discover and validate modulators of up to five therapeutic targets using Curve’s Microcycle proprietary drug discovery platform, initially for #oncology and #neurology indications. bit.ly/3C5q1Wa

My first work trip since Dec 2019 today. A day of meetings in London for CurveTX and a lovely walk to the train station this evening.

🙏 to The Hackenberger Group for hosting me in ☀️Berlin last week. Enjoyed sharing Tavassoli lab & CurveTX research, meeting colleagues & hearing the excellent science at the SynPepBio research retreat. Also a pleasure to give the Marthe-Vogt Seminar and meet colleagues FMP Berlin

Fantastic day with the CurveTX team on Bournemouth beach yesterday. Celebrating our 3rd birthday, and the progress made by the fantastic CurveTX team of scientists with a day of beach sports and team building. Privileged to work with such a talented bunch. #team

We are delighted to welcome Adrian Gill, SVP Medicinal Chemistry at Revolution Medicines, to Curve’s Scientific Advisory Board. We look forward to working with Adrian to advance Curve’s therapeutic programmes that address some of the most challenging cancer targets.

Wow. That lecture by Ali Tavassoli just blew my mind. Cyclic peptides to the rescue!

Wonderful to give the Zervas Award Lecture European Peptide Society meeting in Sitges yesterday. Humbling to be added to the list of awardees which includes some of my scientific heroes.

Ali Tavassoli you gave a great talk - super to see the recent progress your team are making.

Beautiful lecture Ali. So glad I made it to Sitges to hear your elegant award lecture.

Thank you for brewing such excellent hosts UCL Chemistry & HoworkaLab It was great to catch up with colleagues and hear about all the excellent science happening there, and to share some of the research from my academic group and CurveTX

Had a wonderful morning showing CurveTX scientists our new labs and offices in University of Southampton Science Park The building work is progressing well, and we should be moving into our new home in a few weeks 🤞🎉🥂

We are thrilled to be expanding our Leadership Team and SAB. Along with our new facilities at Southampton Science Park, we are well positioned to expand our capabilities from the development of our Microcycle™ platform to the discovery of new drugs. curvetx.com/curve-therapeu…